Douglas Linford, MD
Family Medicine · Coeur D Alene, IDNPI 1821180134
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 314 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 314 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$857
- AstraZeneca$715
- Amgen$493
- Insulet Corporation$484
- Exact Sciences$421
- Boehringer Ingelheim$335
- plus $3K from 28 others
What the payments were for
- Food & beverage$6,09799%
- Education$561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 53 | $857 |
| AstraZeneca | 37 | $715 |
| Amgen(2 entities) | 27 | $493 |
| Insulet Corporation | 5 | $484 |
| Exact Sciences | 22 | $421 |
| Boehringer Ingelheim | 17 | $335 |
| Lilly USA, LLC | 22 | $326 |
| GSK | 18 | $314 |
| Abbott | 6 | $288 |
| AbbVie(2 entities) | 18 | $260 |
| Sanofi-aventis U.S. LLC | 15 | $226 |
| Xeris Pharmaceuticals, Inc. | 10 | $217 |
| Johnson & Johnson | 11 | $196 |
| Pfizer | 12 | $194 |
| Corcept Therapeutics | 1 | $144 |
| Merck | 7 | $112 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| Sunovion Pharmaceuticals Inc. | 6 | $70 |
| Bayer | 4 | $68 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| Acumed LLC | 1 | $43 |
| BETA Bionics, Inc. | 1 | $37 |
| Dexcom, Inc. | 2 | $32 |
| Boston Scientific | 2 | $28 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Genentech USA, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Radius Health, Inc. | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$435
- FREESTYLE LIBRE 3$203
- Korlym$144
How this compares
$6,153 in reported general payments places this provider in the 95th percentile of 803 family medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 348 | $408,662 |
| OzempicSemaglutide | 175 | $189,942 |
| FarxigaDapagliflozin Propanediol | 98 | $125,313 |
| EliquisApixaban | 146 | $124,006 |
| MounjaroTirzepatide | 87 | $113,833 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 68 | $76,511 |
| Methylergonovine Maleate | 12 | $72,450 |
| XareltoRivaroxaban | 63 | $61,156 |
| Tresiba Flextouch U-100Insulin Degludec | 83 | $51,442 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $49,355 |
| Tresiba Flextouch U-200Insulin Degludec | 22 | $41,106 |
| TrulicityDulaglutide | 26 | $39,116 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 42 | $37,695 |
| JanuviaSitagliptin Phosphate | 13 | $20,057 |
| VraylarCariprazine Hcl | 11 | $16,000 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat, Trijardy Xr | $335 | $438,120398 claims |
| Novo NordiskOzempic, Rybelsus | $857 | $204,405191 claims |
| Lilly USA, LLCMounjaro, Trulicity | $326 | $152,948113 claims |
| AstraZenecaFarxiga | $715 | $125,31398 claims |
| PfizerEliquis | $194 | $124,006146 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $314 | $102,120120 claims |
| Johnson & JohnsonXarelto | $196 | $61,15663 claims |
| MerckJanuvia, Janumet | $112 | $33,76324 claims |
| AbbVieVraylar | $260 | $16,00011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 803 family medicine providers in Idaho.
Other family medicine in Coeur D Alene
- Henry DownsCoeur D Alene$69K
- Crystal PyrakCoeur D Alene$46K
- Alyssa ShawCoeur D Alene$5K
- Kelly NelsonCoeur D Alene$4K
- Kenneth CongerSandpoint$266K
- David ButukMeridian$206K
- Anne BroadwayIdaho Falls$184K
- Timothy McHughMeridian$165K
- Phyllis YouBoise$88K
- Ralph SutherlinSt Maries$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.